Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Liminal Biosciences Q4 EPS $(1.72) Up From $(2.90) YoY, Sales $179.43K Down From $238.00K YoY

Author: Benzinga Newsdesk | March 15, 2023 05:50pm
Liminal Biosciences (NASDAQ:LMNL) reported quarterly losses of $(1.72) per share. This is a 40.69 percent increase over losses of $(2.90) per share from the same period last year. The company reported $179.43 thousand in sales this quarter. This is a 24.61 percent decrease over sales of $238.00 thousand the same period last year.

Posted In: LMNL


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist